Innoviva Competitors
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
---|---|---|---|---|---|---|---|---|
MRK | Merck | Outperform |
2
|
$127.57 | $130.51 | 12.10% | 11 | $323.11B |
ABT | Abbott Laboratories | Outperform |
9
|
$105.64 | $118.92 | 19.75% | 7 | $183.77B |
PFE | Pfizer | Outperform |
2
|
$28.16 | $32.87 | 8.31% | 6 | $159.46B |